TotalMarketCap

Lakefront Biotherapeutics

LKFTNasdaq BelgiumHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$2.217 B

$33.65 -1.29%

Close of 6 Nov 2026

As of 6 Nov 2026, Lakefront Biotherapeutics (LKFT) has a market capitalization of $2.22B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

65,897,071

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #86NewAmsterdam PharmaNAMS$2.27B
  2. #87SepternaSEPN$2.22B
  3. #88Lakefront BiotherapeuticsLKFT$2.22B
  4. #89PERRIGOPRGO$2.18B
  5. #90Vera TherapeuticsVERA$2.17B

What if Lakefront Biotherapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$428,499.68

Per share 12,734× higher

Bitcoin $1.53T

$23,185.37

Per share 689× higher

Apple $5.02T

$76,115.41

Per share 2,262× higher

Or at a round number

$5.00B$10.0B$20.0B$50.0B

Where these numbers come from

Share counts and financials for Lakefront Biotherapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.